Show simple item record

dc.contributor.authorHubner, Richard A
dc.contributor.authorGoldstein, R
dc.contributor.authorMitchell, S
dc.contributor.authorJones, A
dc.contributor.authorAshley, S
dc.contributor.authorO'Brien, M E R
dc.contributor.authorPopat, S
dc.date.accessioned2012-05-28T10:36:35Z
dc.date.available2012-05-28T10:36:35Z
dc.date.issued2011-09
dc.identifier.citationInfluence of co-morbidity on renal function assessment by Cockcroft-Gault calculation in lung cancer and mesothelioma patients receiving platinum-based chemotherapy. 2011, 73 (3):356-60 Lung Canceren_GB
dc.identifier.issn1872-8332
dc.identifier.pmid21334759
dc.identifier.doi10.1016/j.lungcan.2011.01.013
dc.identifier.urihttp://hdl.handle.net/10541/226191
dc.description.abstractCreatinine clearance (CrCl) estimation by Cockcroft-Gault calculation (CG) often replaces measurement of glomerular filtration rate (GFR) by [(51)Cr]-ethylenediaminetetraacetic acid clearance (EDTA). Co-morbidity, age, and renal impairment influence the accuracy of CG, whilst the relationship between CG and EDTA has been poorly assessed in lung cancer patients, a population significantly affected by these covariates.
dc.language.isoenen
dc.rightsArchived with thanks to Lung cancer (Amsterdam, Netherlands)en_GB
dc.subject.meshAdult
dc.subject.meshAge Factors
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshComorbidity
dc.subject.meshCreatinine
dc.subject.meshDrug Toxicity
dc.subject.meshFeasibility Studies
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshKidney
dc.subject.meshLung Neoplasms
dc.subject.meshMale
dc.subject.meshMesothelioma
dc.subject.meshMiddle Aged
dc.subject.meshPlatinum Compounds
dc.subject.meshPredictive Value of Tests
dc.subject.meshReference Values
dc.subject.meshRetrospective Studies
dc.subject.meshRisk
dc.subject.meshSensitivity and Specificity
dc.titleInfluence of co-morbidity on renal function assessment by Cockcroft-Gault calculation in lung cancer and mesothelioma patients receiving platinum-based chemotherapy.en
dc.typeArticleen
dc.contributor.departmentDept Medical Oncology, Christie Hospital, Manchester M20 4BX, UK.en_GB
dc.identifier.journalLung Canceren_GB
html.description.abstractCreatinine clearance (CrCl) estimation by Cockcroft-Gault calculation (CG) often replaces measurement of glomerular filtration rate (GFR) by [(51)Cr]-ethylenediaminetetraacetic acid clearance (EDTA). Co-morbidity, age, and renal impairment influence the accuracy of CG, whilst the relationship between CG and EDTA has been poorly assessed in lung cancer patients, a population significantly affected by these covariates.


Files in this item

This item appears in the following Collection(s)

Show simple item record